+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transdermal Patches Market - Global Forecast 2026-2032- Product Image
Transdermal Patches Market - Global Forecast 2026-2032- Product Image
Sale

Transdermal Patches Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5519528
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transdermal Patches Market is projected to reach USD 7.02 Billion in 2026. It is expected to continue growing at a CAGR of 5.69%, reaching USD 9.82 Billion by 2032.

Transdermal patches are drug-device combination products designed to deliver active pharmaceutical ingredients through the skin for systemic or localized therapeutic effect. Their clinical value is anchored in controlled drug release, improved dosing adherence, avoidance of first-pass hepatic metabolism, and reduced gastrointestinal exposure compared with many oral therapies. The category spans passive diffusion systems, drug-in-adhesive patches, reservoir and matrix designs, microneedle-enabled platforms, iontophoretic systems, and emerging smart patches that connect therapy delivery with digital monitoring. Established applications include pain management, nicotine replacement, hormone therapy, neurological disorders, cardiovascular care, and motion sickness, while research pipelines continue to evaluate transdermal delivery for biologics, vaccines, peptides, and complex molecules. Regulatory scrutiny remains high because product performance depends on formulation stability, adhesive integrity, skin permeation, residual drug levels, extractables and leachables, wearability, and human factors. As healthcare systems prioritize patient-centric treatment, chronic disease management, home-based care, and medication adherence, transdermal patch innovation is increasingly shaped by material science, precision dosing, digital health integration, and lifecycle management of proven therapeutics.

Transformative Shifts in the Transdermal Patch Landscape

The transdermal patches landscape is undergoing a structural shift from conventional passive delivery systems toward advanced platforms that combine pharmacology, polymer engineering, skin science, and digital therapeutics. Demand is increasingly influenced by the need for long-acting, self-administered therapies that reduce dosing frequency and support outpatient care. Advances in pressure-sensitive adhesives, permeation enhancers, backing films, release liners, and skin-compatible excipients are improving patch comfort, adhesion, and delivery consistency across diverse patient populations. Microneedle patches are expanding the scientific frontier by enabling delivery of larger molecules that traditionally face skin-barrier limitations, while iontophoresis and ultrasound-assisted approaches are being explored for controllable delivery profiles. Sustainability is also becoming more relevant as stakeholders evaluate packaging reduction, solvent management, and responsible disposal of residual drug content. At the same time, regulatory agencies continue to emphasize bioequivalence, in vitro release testing, skin irritation and sensitization assessment, quality-by-design principles, and robust post-market surveillance. These shifts are repositioning transdermal drug delivery from a convenience-oriented dosage format into a strategic platform for adherence, differentiation, and chronic care optimization.

Cumulative Impact of Artificial Intelligence on Transdermal Patches

Artificial intelligence is beginning to influence transdermal patch development across discovery, formulation, manufacturing, clinical evaluation, and post-market monitoring. In formulation design, machine learning models can help analyze relationships among molecular weight, lipophilicity, melting point, hydrogen bonding, adhesive chemistry, and skin permeability to identify drug candidates with suitable transdermal potential. AI-assisted simulation supports optimization of release kinetics, excipient selection, and permeation enhancer combinations, reducing reliance on iterative trial-and-error experimentation. In manufacturing, computer vision and predictive analytics can improve inspection of coating uniformity, die-cut precision, lamination defects, adhesive spread, and packaging integrity. Digital twins and process analytics support quality-by-design implementation for critical parameters such as coating thickness, drying temperature, residual solvents, and dose uniformity. In clinical and real-world settings, AI-enabled wearables and connected patch systems can help interpret adherence signals, skin response patterns, and therapy utilization trends, while preserving privacy and regulatory compliance. The cumulative impact is not a replacement of pharmaceutical science but an acceleration of evidence generation, risk detection, process control, and patient personalization in transdermal drug delivery.

Key Regional Insights Across the Transdermal Patches Market

Asia-Pacific is increasingly important for transdermal patches due to its large chronic disease burden, expanding healthcare access, and established pharmaceutical manufacturing capabilities across China, India, Japan, South Korea, Australia, and ASEAN economies. Regional innovation is supported by active research in microneedle systems, cosmetic-medical convergence, and cost-efficient manufacturing, while regulatory harmonization efforts continue to improve product quality expectations. North America remains a highly advanced environment for transdermal drug delivery, supported by rigorous regulatory pathways, strong clinical research infrastructure, high adoption of nicotine replacement and pain-management patches, and growing interest in connected medication adherence tools. Latin America is characterized by rising demand for accessible chronic disease therapies, increasing retail pharmacy penetration, and opportunities for transdermal formats that reduce dosing complexity, particularly in Brazil and Mexico. Europe demonstrates strong regulatory maturity, emphasis on product safety, pharmacovigilance, and sustainable healthcare, with demand shaped by aging populations and guideline-driven chronic disease management. The Middle East is advancing through healthcare modernization, hospital infrastructure investment, and interest in premium drug delivery formats, especially across Gulf economies. Africa presents a longer-term opportunity where transdermal patches can support adherence and simplified administration, but growth depends on affordability, cold-chain independence, regulatory capacity, supply reliability, and clinician awareness.

Key Group Insights Shaping Transdermal Patch Adoption

ASEAN economies are gaining relevance for transdermal patches as healthcare systems expand access to chronic disease treatment and regional manufacturing networks mature, with demand influenced by affordability, tropical climate stability, and pharmacy-led access. The GCC is shaped by high healthcare spending, noncommunicable disease priorities, and modernization of hospital and outpatient care, creating interest in patient-friendly patch therapies that support adherence and lifestyle compatibility. The European Union provides one of the most structured regulatory environments for transdermal drug delivery, emphasizing quality, safety, pharmacovigilance, environmental considerations, and evidence-based substitution for generic and hybrid products. BRICS countries combine large patient populations, expanding domestic pharmaceutical production, and growing research capabilities, making them important for both demand and supply-side development of transdermal systems; however, regulatory consistency, reimbursement variation, and access inequality remain critical factors. G7 countries are characterized by advanced clinical infrastructure, stronger intellectual property ecosystems, and demand for differentiated drug-device products that improve adherence and outcomes in aging populations. NATO member countries, many of which overlap with mature healthcare markets, show demand patterns influenced by resilient medical supply chains, regulatory alignment, and preparedness for self-administered therapies that can reduce burden on healthcare facilities.

Key Country Insights for Transdermal Patch Strategies

The United States remains a leading environment for transdermal patches due to its established regulatory framework for drug-device combination products, broad experience with generic patch approvals, and strong focus on adherence in chronic care. Canada reflects similar safety and quality priorities, with healthcare decisions influenced by public reimbursement evaluation and patient access considerations. Mexico and Brazil are important Latin American markets where rising chronic disease management needs and retail pharmacy channels support broader acceptance of patch-based therapy, although affordability and reimbursement remain central. In Europe, the United Kingdom emphasizes cost-effectiveness and real-world value, Germany prioritizes high-quality pharmaceutical standards and evidence-based care, France maintains strong pharmacovigilance and reimbursement assessment, Italy and Spain are shaped by aging populations and public healthcare efficiency needs, and Russia combines domestic production priorities with demand for accessible chronic therapies. China is advancing rapidly through pharmaceutical modernization, local innovation, and expanding clinical research, while India contributes major manufacturing strengths and rising domestic demand for affordable transdermal delivery. Japan has long-standing expertise in patch technology, driven by aging demographics, high quality expectations, and patient preference for convenient dosage forms. Australia supports uptake through regulated medicine access and chronic disease care frameworks, while South Korea is notable for advanced materials research, microneedle innovation, and strong medical technology capabilities.

Actionable Recommendations for Transdermal Patch Industry Leaders

Industry leaders should prioritize patient-centered patch design by improving adhesion across skin types, reducing irritation and sensitization risk, and validating wearability under real-world conditions such as heat, humidity, sweating, and movement. Development teams should apply quality-by-design principles early, linking critical material attributes and process parameters to release performance, dose uniformity, residual drug content, and adhesive behavior. Companies should invest in robust in vitro and in vivo correlation strategies, comparative pharmacokinetic evidence, and human factors testing to reduce regulatory risk. Portfolio strategies should focus on therapies where transdermal delivery provides clear clinical utility, including adherence-sensitive chronic conditions, drugs with gastrointestinal limitations, and molecules that benefit from controlled plasma exposure. Manufacturing leaders should strengthen supplier qualification for adhesives, films, liners, excipients, and active ingredients, while improving process analytical technology and defect detection. Digital integration should be pursued selectively, with clear value in adherence monitoring, dose confirmation, or safety follow-up rather than technology addition for its own sake. Market access teams should build evidence around adherence improvement, reduced dosing burden, patient preference, and health-system efficiency without overstating outcomes. Sustainability initiatives should address solvent use, packaging, waste handling, and residual drug disposal to align with evolving environmental expectations.

Research Methodology for Transdermal Patches Analysis

The research methodology for evaluating the transdermal patches landscape combines structured secondary research, expert-led validation, regulatory review, and evidence triangulation. Secondary research includes peer-reviewed scientific literature, pharmacopoeial references, regulatory guidance documents, patent filings, clinical trial registries, public health data, and government healthcare publications related to transdermal drug delivery, skin permeation, drug-device combination products, and pharmaceutical quality systems. Regulatory assessment considers established expectations for bioequivalence, in vitro release testing, adhesion studies, skin irritation and sensitization, human factors, extractables and leachables, manufacturing controls, and pharmacovigilance. Qualitative validation is derived from subject-matter expertise across formulation science, pharmaceutical manufacturing, clinical development, regulatory affairs, and market access. Findings are triangulated by comparing scientific feasibility, therapeutic relevance, regulatory requirements, regional healthcare dynamics, and adoption barriers. The methodology avoids unsupported assumptions and excludes market sizing, market share, and forecasting. Emphasis is placed on verified trends, documented technological developments, and observable healthcare system drivers that influence transdermal patch development and commercialization.

Conclusion: Future Direction of Transdermal Patches

Transdermal patches are evolving from established controlled-release dosage forms into sophisticated drug delivery platforms that align with the healthcare shift toward adherence, convenience, and decentralized care. Advances in adhesives, permeation enhancement, microneedles, formulation modeling, and connected monitoring are expanding the technical potential of transdermal delivery while increasing expectations for safety, evidence, and manufacturing precision. Regional dynamics differ significantly: mature markets emphasize regulatory rigor, clinical value, and product differentiation, while emerging regions prioritize access, affordability, and scalable supply. Artificial intelligence is set to enhance formulation screening, process control, defect detection, and real-world adherence analysis, but success will depend on disciplined validation and regulatory transparency. For industry leaders, the strongest opportunities will come from matching the right molecule, delivery technology, patient need, and evidence strategy. Organizations that combine pharmaceutical quality, patient-centric design, robust regulatory planning, and supply-chain resilience will be best positioned to advance transdermal patches as a trusted component of modern therapeutic care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transdermal Patches Market, by Product Type
7.1. Introduction
7.2. Drug-In-Adhesive Patches
7.3. Matrix Patches
7.4. Micro-Reservoir Patches
8. Transdermal Patches Market, by Active Ingredient
8.1. Introduction
8.2. Buprenorphine
8.3. Clonidine
8.4. Fentanyl
8.5. Lidocaine
8.6. Nicotine
9. Transdermal Patches Market, by Delivery System
9.1. Introduction
9.2. Controlled Release
9.3. Direct Release
10. Transdermal Patches Market, by Layer Type
10.1. Introduction
10.2. Multi-Layer
10.3. Single Layer
11. Transdermal Patches Market, by Adhesive Type
11.1. Introduction
11.2. Acrylic-Based Adhesives
11.3. Silicone-Based Adhesives
11.4. Rubber-Based
12. Transdermal Patches Market, by Application
12.1. Introduction
12.2. Cardiovascular Disorders
12.2.1. Clonidine Patches
12.2.2. Isosorbide Dinitrate Patches
12.3. Hormone Replacement Therapy
12.3.1. Combination Hormone Patches
12.3.2. Estrogen Patches
12.3.3. Progestin Patches
12.4. Neurological Conditions
12.5. Pain Management
12.5.1. Diclofenac-Based
12.5.2. Fentanyl-Based
12.5.3. Lidocaine-Based
12.6. Smoking Cessation
12.7. Wound Management
13. Transdermal Patches Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Homecare Settings
13.4. Hospitals & Clinics
13.5. Research & Academic Institutes
14. Transdermal Patches Market, by Distribution Channel
14.1. Introduction
14.2. Online
14.3. Offline
15. Transdermal Patches Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. Europe
15.4. North America
15.5. Latin America
15.6. Africa
15.7. Middle East
16. Transdermal Patches Market, by Group
16.1. Introduction
16.2. NATO
16.3. G7
16.4. BRICS
16.5. European Union
16.6. ASEAN
16.7. GCC
17. Transdermal Patches Market, by Country
17.1. Introduction
17.2. China
17.3. United States
17.4. Japan
17.5. India
17.6. Germany
17.7. United Kingdom
17.8. Australia
17.9. France
17.10. South Korea
17.11. Italy
17.12. Canada
17.13. Russia
17.14. Brazil
17.15. Mexico
17.16. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. 3M Company
19.2. AdhexPharma
19.3. Agile Therapeutics Inc.
19.4. Bayer AG
19.5. Boehringer Ingelheim International GmbH
19.6. Corium LLC
19.7. GSK plc
19.8. Hisamitsu Pharmaceutical Co., Inc.
19.9. Johnson & Johnson Services Inc.
19.10. Kindeva Drug Delivery LP
19.11. Lavipharm SA
19.12. Lead Chemical Co., Ltd.
19.13. LTS Lohmann Therapie-Systeme AG
19.14. Luye Pharma Group Ltd.
19.15. MedPharm Ltd.
19.16. Nitto Denko Corporation
19.17. Novartis International AG
19.18. Noven Pharmaceuticals Inc.
19.19. Sparsha Pharma International Pvt. Ltd.
19.20. Teikoku Pharma USA Inc.
19.21. Teva Pharmaceutical Industries Ltd.
19.22. UCB SA
19.23. Viatris Inc.
19.24. Zydus Lifesciences Ltd.
20. Key Experts
List of Figures
FIGURE 1. Global Transdermal Patches Market, Years Considered for the Study
FIGURE 2. Global Transdermal Patches Market, Research Design
FIGURE 3. Global Transdermal Patches Market, Research Framework
FIGURE 4. Global Transdermal Patches Market, Data Triangulation
FIGURE 5. Global Transdermal Patches Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Transdermal Patches Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Transdermal Patches Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Transdermal Patches Market Size, by Active Ingredient, 2025 vs 2032 (%)
FIGURE 9. Global Transdermal Patches Market Size, by Active Ingredient, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Transdermal Patches Market Size, by Delivery System, 2025 vs 2032 (%)
FIGURE 11. Global Transdermal Patches Market Size, by Delivery System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Transdermal Patches Market Size, by Layer Type, 2025 vs 2032 (%)
FIGURE 13. Global Transdermal Patches Market Size, by Layer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Transdermal Patches Market Size, by Adhesive Type, 2025 vs 2032 (%)
FIGURE 15. Global Transdermal Patches Market Size, by Adhesive Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Transdermal Patches Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Transdermal Patches Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Transdermal Patches Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Transdermal Patches Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Transdermal Patches Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Transdermal Patches Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Transdermal Patches Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Transdermal Patches Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Transdermal Patches Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Transdermal Patches Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Transdermal Patches Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Transdermal Patches Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Transdermal Patches Market Segmentation & Coverage
TABLE 2. Global Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 3. Global Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Drug-In-Adhesive Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Drug-In-Adhesive Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Drug-In-Adhesive Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Matrix Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Matrix Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Matrix Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Micro-Reservoir Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Micro-Reservoir Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Micro-Reservoir Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 14. Global Buprenorphine Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Buprenorphine Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Buprenorphine Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Clonidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Clonidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Clonidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Fentanyl Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Fentanyl Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Fentanyl Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Lidocaine Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Lidocaine Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Lidocaine Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Nicotine Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Nicotine Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Nicotine Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 30. Global Controlled Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Controlled Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Controlled Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Direct Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Direct Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Direct Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 37. Global Multi-Layer Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Multi-Layer Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Multi-Layer Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Single Layer Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Single Layer Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Single Layer Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 44. Global Acrylic-Based Adhesives Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Acrylic-Based Adhesives Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Acrylic-Based Adhesives Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Silicone-Based Adhesives Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Silicone-Based Adhesives Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Silicone-Based Adhesives Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Rubber-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Rubber-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Rubber-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Cardiovascular Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cardiovascular Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cardiovascular Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Clonidine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Clonidine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Clonidine Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Isosorbide Dinitrate Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Isosorbide Dinitrate Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Isosorbide Dinitrate Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Hormone Replacement Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Hormone Replacement Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Hormone Replacement Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Combination Hormone Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Combination Hormone Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Combination Hormone Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Estrogen Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Estrogen Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Estrogen Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Progestin Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Progestin Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Progestin Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Neurological Conditions Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Neurological Conditions Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Neurological Conditions Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Diclofenac-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Diclofenac-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Diclofenac-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Fentanyl-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Fentanyl-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Fentanyl-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Lidocaine-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Lidocaine-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Lidocaine-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Smoking Cessation Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Smoking Cessation Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Smoking Cessation Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Wound Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Wound Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Wound Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Research & Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Research & Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Research & Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Europe Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Europe Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. Europe Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 132. Europe Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 133. Europe Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 134. Europe Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 135. Europe Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Europe Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 137. Europe Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 138. Europe Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 139. Europe Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Europe Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. North America Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. North America Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. North America Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 144. North America Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 145. North America Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 146. North America Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 147. North America Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. North America Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 149. North America Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 150. North America Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 151. North America Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. North America Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Latin America Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Latin America Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Latin America Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 156. Latin America Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 157. Latin America Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 158. Latin America Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 159. Latin America Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Latin America Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 161. Latin America Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 162. Latin America Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 163. Latin America Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Latin America Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Africa Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Africa Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. Africa Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 168. Africa Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 169. Africa Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 170. Africa Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 171. Africa Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Africa Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 173. Africa Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 174. Africa Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 175. Africa Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Africa Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Middle East Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Middle East Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Middle East Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 180. Middle East Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 181. Middle East Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 182. Middle East Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 183. Middle East Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Middle East Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 185. Middle East Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 186. Middle East Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 187. Middle East Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Middle East Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Global Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. NATO Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. NATO Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. NATO Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 193. NATO Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 194. NATO Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 195. NATO Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 196. NATO Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. NATO Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 198. NATO Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 199. NATO Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 200. NATO Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. NATO Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. G7 Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. G7 Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. G7 Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 205. G7 Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 206. G7 Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 207. G7 Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 208. G7 Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. G7 Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 210. G7 Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 211. G7 Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 212. G7 Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. G7 Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. BRICS Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. BRICS Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. BRICS Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 217. BRICS Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 218. BRICS Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 219. BRICS Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 220. BRICS Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. BRICS Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 222. BRICS Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 223. BRICS Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 224. BRICS Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. BRICS Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. European Union Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. European Union Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. European Union Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 229. European Union Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 230. European Union Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 231. European Union Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 232. European Union Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. European Union Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 234. European Union Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 235. European Union Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 236. European Union Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. European Union Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. ASEAN Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. ASEAN Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. ASEAN Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 241. ASEAN Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 242. ASEAN Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 243. ASEAN Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 244. ASEAN Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. ASEAN Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 246. ASEAN Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 247. ASEAN Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 248. ASEAN Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. ASEAN Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. GCC Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 251. GCC Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. GCC Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 253. GCC Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 254. GCC Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 255. GCC Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 256. GCC Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. GCC Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 258. GCC Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 259. GCC Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 260. GCC Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. GCC Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Global Transdermal Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 263. China Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 264. China Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. China Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 266. China Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 267. China Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 268. China Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 269. China Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. China Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 271. China Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 272. China Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 273. China Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. China Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. United States Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 276. United States Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. United States Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 278. United States Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 279. United States Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 280. United States Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 281. United States Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. United States Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 283. United States Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 284. United States Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 285. United States Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. United States Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 287. Japan Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 288. Japan Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. Japan Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 290. Japan Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 291. Japan Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 292. Japan Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 293. Japan Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Japan Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 295. Japan Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 296. Japan Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 297. Japan Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Japan Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 299. India Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 300. India Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 301. India Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 302. India Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 303. India Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 304. India Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 305. India Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. India Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 307. India Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 308. India Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 309. India Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. India Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 311. Germany Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 312. Germany Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 313. Germany Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 314. Germany Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 315. Germany Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 316. Germany Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 317. Germany Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. Germany Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 319. Germany Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 320. Germany Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 321. Germany Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Germany Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. United Kingdom Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 324. United Kingdom Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 325. United Kingdom Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 326. United Kingdom Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 327. United Kingdom Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 328. United Kingdom Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 329. United Kingdom Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. United Kingdom Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 331. United Kingdom Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 332. United Kingdom Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 333. United Kingdom Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. United Kingdom Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 335. Australia Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 336. Australia Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 337. Australia Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 338. Australia Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 339. Australia Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 340. Australia Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 341. Australia Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 342. Australia Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 343. Australia Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 344. Australia Transdermal Patches Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 345. Australia Transdermal Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 346. Australia Transdermal Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. France Transdermal Patches Market Size, 2017-2032 (USD Million)
TABLE 348. France Transdermal Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 349. France Transdermal Patches Market Size, by Active Ingredient, 2017-2032 (USD Million)
TABLE 350. France Transdermal Patches Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 351. France Transdermal Patches Market Size, by Layer Type, 2017-2032 (USD Million)
TABLE 352. France Transdermal Patches Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 353. France Transdermal Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 354. France Transdermal Patches Market Size, by Cardiovascular Disorders, 2017-2032 (USD Million)
TABLE 355. France Transdermal Patches Market Size, by Hormone Replacement Therapy, 2017-2032 (USD Million)
TABLE 356. France Transdermal Patches Market Size,

Companies Mentioned

  • 3M Company
  • AdhexPharma
  • Agile Therapeutics Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Corium LLC
  • GSK plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services Inc.
  • Kindeva Drug Delivery LP
  • Lavipharm SA
  • Lead Chemical Co., Ltd.
  • LTS Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd.
  • MedPharm Ltd.
  • Nitto Denko Corporation
  • Novartis International AG
  • Noven Pharmaceuticals Inc.
  • Sparsha Pharma International Pvt. Ltd.
  • Teikoku Pharma USA Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.02 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.82 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Hormonal Transdermal Patches Market - Global Forecast 2025-2032 - Product Image

Hormonal Transdermal Patches Market - Global Forecast 2025-2032

  • Report
  • 180 Pages
  • Global
From
Scopolamine Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Transdermal Patches, Tablets / Capsules, Injectable Solution, Oral Drops & Others), Application, Source, Distribution Channel - Product Image

Scopolamine Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Transdermal Patches, Tablets / Capsules, Injectable Solution, Oral Drops & Others), Application, Source, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
2025 Global Forecast for Transdermal Patches Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Transdermal Patches Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Transdermal Drug Delivery System Market - Global Forecast 2026-2032 - Product Image

Transdermal Drug Delivery System Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Transdermal Drug Delivery - Global Strategic Business Report - Product Image

Transdermal Drug Delivery - Global Strategic Business Report

  • Report
  • 201 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.